Agios Pharmaceuticals | AGIO - PE价格收益



金融业
股票价格
USD
资产
USD 1.11B
现金及等价物
USD 99.65M
销售成本
USD 1.32M
流动资产
USD 717.67M
流动负债
USD 70.22M
债务
USD 35.75M
EBIT
USD -110.03M
EBITDA
USD -108.66M
员工
486
EPS每股收益
USD -1.69
股本和储备
USD 1.03B
销售毛利
USD 19.43M
债务利息支出
USD 1.11B
利息收入
USD 10.8M
贷款资金
USD 1.06M
市值
USD 1.89B
净收入
USD -99.11M
营业费用
USD 130.77M
营业利润
USD -110.03M
普通股股本
USD 59.34M
PE价格收益
3.56
税前利润
USD -99.11M
销售收入
USD 44.74M
销售和管理费用
USD 38.46M
股票
USD 35.75M
贸易债权人
USD 16.35M
应收帐款人
USD 16.13M


Pe 更改 日
AbbVie 23.96 0.93 2026-06
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amgen 18.07 1.77 2026-06
Arrowhead Research 39.19 0 2026-06
Astellas Pharma 9.41 6.06 2026-06
AstraZeneca 25.34 4.25 2026-06
Bayer 4.14 0.74 2026-06
Biogen 23.23 9.53 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
Daiichi Sankyo 20.14 0.6 2026-06
Eli Lilly 32.9 7.37 2026-06
Exelixis 18.02 4.11 2026-06
Gilead Sciences 13.51 4.2 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
Incyte 14.45 0.9 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Merck 32.26 15.74 2026-06
Moderna 27.22 14.51 2023-06
Novartis 22.41 2.24 2026-06
Novartis 21.36 3.57 2026-03
Pfizer 11.48 2.16 2026-06
Puma Biotechnology 13.93 44.88 2024-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Sarepta Therapeutics 27.27 0 2026-03
Vertex Pharmaceuticals 28.05 2.22 2026-06